Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Actin vs PeterMD

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.0

Actin

Best for affordable compounded semaglutide with B12 enhancement
★★★3.5

Starting at $133/mo

Compounded SemaglutideB12 Enhanced
Visit Actin
7.2

PeterMD

Best for men seeking flat-priced compounded GLP-1 access alongside TRT or peptide therapy
★★★3.6

Starting at $135/mo

CompoundedSemaglutideTirzepatideMen's Health
Visit PeterMD

Side-by-Side Comparison

FeatureActinPeterMD
Overall Score7.0/107.2/10
Starting Price$133/mo$135/mo
Editorial Rating3.5 ★ /53.6 ★ /5
Features2 features6 features
States Available042
Compounded✓ Yes✓ Yes
Brand Name
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

Actin

Pros

  • Semaglutide + B12 combination for added energy support
  • Transparent pricing — exact cost shown upfront with no hidden fees
  • Competitive starting price from $133

Cons

  • Semaglutide only — no tirzepatide or liraglutide
  • No visible LegitScript or PCAB accreditation
  • State availability not disclosed
  • Broader platform (hormones, sexual wellness, hair health)

PeterMD

Pros

  • Flat pricing across semaglutide dose tiers (0.25mg through 2.4mg)
  • Both semaglutide and tirzepatide available
  • No long-term commitment after the 2-month intro period
  • Month-to-month cancellation via patient portal, no cancellation fee
  • Covers men's-health adjacencies (TRT, peptides, ED, anti-aging) in one account

Cons

  • Initial $270 two-month payment is non-refundable
  • Not available in 8 states (AL, AR, CA, HI, ID, MI, NC, TX)
  • Men's-only branding — will not appeal to women seeking GLP-1 access
  • Pharmacy partner and named clinicians not publicly disclosed

Our Verdict

Winner: PeterMDScore: 7.2/10

PeterMD edges out Actin with a higher overall score of 7.2/10 and is particularly strong for men seeking flat-priced compounded GLP-1 access alongside TRT or peptide therapy. Actin remains a solid alternative, especially if you're looking for affordable compounded semaglutide with B12 enhancement.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.